134 related articles for article (PubMed ID: 37643508)
21. Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology.
Shah N; Mustafa SS; Vinh DC
Crit Rev Oncol Hematol; 2023 Jan; 181():103896. PubMed ID: 36528276
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies.
Jolles S; Smith BD; Vinh DC; Mallick R; Espinoza G; DeKoven M; Divino V
Leuk Lymphoma; 2022 Jan; 63(1):64-73. PubMed ID: 34702119
[TBL] [Abstract][Full Text] [Related]
23. Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
van Zelm MC; Pumar M; Shuttleworth P; Aui PM; Smart JM; Grigg A; Bosco JJ
Front Immunol; 2019; 10():895. PubMed ID: 31105705
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies.
Shields AM; Faustini SE; Young S; Terjesen S; McCarthy NI; Anderson RL; Drayson MT; Richter AG
EJHaem; 2023 May; 4(2):339-349. PubMed ID: 37206270
[TBL] [Abstract][Full Text] [Related]
25. Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy.
Richter J; Davids MS; Anderson-Smits C; Kamieniak M; Ren K; Hull M; Multani JK; Shah D; Siffel C
Clin Lymphoma Myeloma Leuk; 2024 Apr; ():. PubMed ID: 38734499
[TBL] [Abstract][Full Text] [Related]
26. Secondary immunodeficiency in lymphoproliferative malignancies.
Friman V; Winqvist O; Blimark C; Langerbeins P; Chapel H; Dhalla F
Hematol Oncol; 2016 Sep; 34(3):121-32. PubMed ID: 27402426
[TBL] [Abstract][Full Text] [Related]
27. Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.
Sánchez-Ramón S; Dhalla F; Chapel H
Front Immunol; 2016; 7():317. PubMed ID: 27597852
[TBL] [Abstract][Full Text] [Related]
28. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.
Sarmati L; Andreoni M; Antonelli G; Arcese W; Bruno R; Coppola N; Gaeta GB; Galli M; Girmenia C; Mikulska M; Pane F; Perno CF; Picardi M; Puoti M; Rambaldi A; Svicher V; Taliani G; Gentile G
Clin Microbiol Infect; 2017 Dec; 23(12):935-940. PubMed ID: 28668466
[TBL] [Abstract][Full Text] [Related]
29. Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective Analysis.
Dimou M; Iliakis T; Maltezas D; Bitsani A; Kalyva S; Koudouna A; Kotsanti S; Petsa P; Papaioannou P; Kyrtsonis MC; Panayiotidis P
Anticancer Res; 2018 Jul; 38(7):4187-4191. PubMed ID: 29970548
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles.
de Haan N; van Tol MJD; Driessen GJ; Wuhrer M; Lankester AC
Front Immunol; 2018; 9():1238. PubMed ID: 29915589
[TBL] [Abstract][Full Text] [Related]
31. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
[TBL] [Abstract][Full Text] [Related]
32. Hematological Malignancies Associated With Primary Immunodeficiency Disorders.
Duan L; Grunebaum E
Clin Immunol; 2018 Sep; 194():46-59. PubMed ID: 29966714
[TBL] [Abstract][Full Text] [Related]
33. Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians.
Kampouri E; Walti CS; Gauthier J; Hill JA
Expert Rev Hematol; 2022 Apr; 15(4):305-320. PubMed ID: 35385358
[TBL] [Abstract][Full Text] [Related]
34. T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.
Kajimoto Y; Terasaki Y; Terasaki M; Kunugi S; Okabe Y; Wakita S; Inokuchi K; Shimizu A
Diagn Pathol; 2020 Oct; 15(1):125. PubMed ID: 33036636
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation.
Ueda M; Berger M; Gale RP; Lazarus HM
Blood Rev; 2018 Mar; 32(2):106-115. PubMed ID: 28958644
[TBL] [Abstract][Full Text] [Related]
36. [Advances in the target therapy of hematological malignancies].
Niu T; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):642-6. PubMed ID: 25286692
[TBL] [Abstract][Full Text] [Related]
37. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
[No Abstract] [Full Text] [Related]
38. [Efficacy and safety of hepatitis B re-vaccination in children after completion of chemotherapy and(or) hematopoietic stem cell transplantation].
Yuan Q; Zhou F; Zhang H; Cao Q; Chen WJ; Fei Y; Luo CY; Gao YJ
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):802-806. PubMed ID: 32987458
[No Abstract] [Full Text] [Related]
39. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review.
Wijetilleka S; Mukhtyar C; Jayne D; Ala A; Bright P; Chinoy H; Harper L; Kazmi M; Kiani-Alikhan S; Li C; Misbah S; Oni L; Price-Kuehne F; Salama A; Workman S; Wrench D; Karim MY
Autoimmun Rev; 2019 May; 18(5):535-541. PubMed ID: 30844552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
